Abstract
The HB4C5 and HF10B4 cell lines are human-human hybridomas producing human IgM monoclonal antibodies (MAbs) reactive to porcine carboxypeptidase A (CPase), but not to double stranded DNA (ds DNA). We obtained G418-resistant HB4C5 and HF10B4 cells by an introduction of pSV2-neo DNA. Almost all of the G418-resistant clones produced MAbs reactive to not only the CPase but the ds DNA. The results of the inhibition ELISA suggested that the cross-reactivity of the antibodies from G418-resistant clones to CPase and ds DNA was responsible for the alteration on their antigen specificity. HB4C5 and HF10B4 cells and their G418-resistant clones produced antibodies having glycosylated λ chain. The antibodies produced by tunicamycin-treated G418-resistant subclones of HB4C5 and HF10B4 lost the ability to bind to ds DNA, but retained the ability to bind to CPase. These results suggest that an introduction of pSV2-neo DNA into these hybridomas alters the specificities of their MAbs, and that the alteration to antigen binding specificities of their MAbs may be associated with glycosylation of the MAbs by these hybridomas.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Chien, NC, Pollock, RR, Desaymard, C and Scharff, MD (1988) Point mutations cause the somatic diversification of IgM and IgG2a antiphosphorylcholine antibodies. J. Exp. Med. 167: 954–973.
Chien, NC, Roberts, VA, Giusti, AM, Scharff, MD and Getzoff, ED (1989) Significant structural and functional change of an antigen-binding site by a distant amino acid substitution: Proposal of a structural mechanism. Proc. Natl. Acad. Sci. U.S.A. 86: 5532–5536.
Cook, WD, Rudikoff, S, Giusti, AM and Scharff, MD (1982) Somatic mutation in a cultured mouse myeloma cell affects antigen binding. Proc. Natl. Acad. Sci. U.S.A. 79: 1240–1244.
Diamond, B and Scharff, MD (1984) Somatic mutation of the T15 heavy chain gives rise to an antibody with autoantibody specificity. Proc. Natl. Acad. Sci. U.S.A. 81: 5841–5844.
Elbein, AD (1981) The tunicamycins-useful tools for studies on glycoproteins. Trends Biochem. Sci. 6: 216–223.
Giusti, AM, Chien, NC, Zack, DJ, Shin, S-U and Scharff, MD (1987) Somatic diversification of S107 from an antiphosphocholine to an anti-DNA autoantibody is due to a single base change in its heavy chain variable region. Proc. Natl. Acad. Sci. U.S.A. 84: 2926–2930.
Griffiths, GM, Berek, C, Kaartinen, M and Milstein, C (1984) Somatic mutation and the matuation of immune response to 2-phenyl oxazolone. Nature 312: 271–275.
Hashizume, S, Mochizuki, K, Kamei, M, Kuroda, K, Kato, M, Sato, S, Yasumoto, K, Nakahashi, H, Tsuchimoto, M, Muraoka, M, Nomoto, K and Murakami, H (1991) Serodiagnosis of cancer, using porcine carboxypeptidase A recognized by human monoclonal antibody HB4C5. Hum. Antibod. Hybridomas 2: 150–155.
Hashizume, S, Murakami, H, Kamei, M, Hirose, S, Shirai, T, Yamada, K and Omura, H (1987) Specificity of anti-polynucleotide monoclonal antibodies from human-human hybridomas.In Vitro Cell. Dev. Biol. 23: 53–56.
Karawajew, L, Rudchenko, S, Wlasik, T, Trakht, I and Rakitskaya, V (1990) Flow sorting of hybrid hybridomas using the DNA stain Hoechst 33342. J. Immunol. Methods 129: 277–282.
Kerbel, RS, Waghorne, C, Man, MS, Elliott, B and Breitman, ML (1987) Alteration of the tumorigenic and metastatic properties of neoplastic cells is associated with the process of calcium phosphate-mediated DNA transfection. Proc. Natl. Acad. Sci. U.S.A. 84: 1263–1267.
Matsuuchi, L, Wims, LA and Morrison, SL (1981) A variant of the dextran-binding mouse plasmacytoma J558 with altered glycosylation of its heavy chain and decreased reactivity with polymeric dextran. Biochemistry 20: 4827–4835.
Murakami, H, Hashizume, S, Ohashi, H, Shinohara, K, Yasumoto, K, Nomoto, K and Omura, H (1985) Human-human hybridomas secreting antibodies specific to human lung carcinoma.In Vitro Cell. Dev. Biol., 21: 593–596.
Murakami, H (1989) Serum-free media used for cultivation of hybridomas. In:Mizrahi, A (ed.) Advance in Biotechnological Processes, Vol. 11, pp 107–141, Alan R. Liss, Inc., New York.
Murakami H, Shinmoto H, Dosako S and Yamada K (1989) Engineered human antibodies with dual specificities. In: Kotyket al. (eds.) Highlights Modern Biochem. 2: 1351–1360.
Moran, TM, Usuba, O, Shapio, E, Rubinstein, LJ, Ito, M and Bona, CA (1990) A novel technique for the production of hybrid antibodies. J. Immunol. Methods 129: 199–205.
Rudikoff, S, Giesti, AM, Cook, WD and Scharff, MD (1982) Single amino acid substitution altering antigen-binding specificity. Proc. Natl. Acad. Sci. U.S.A. 79: 1979–1983.
Southern, PJ and Berg, P (1982) Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promoter. J. Mol. Appl. Genet. 1: 327–341.
Sox, HCJr and Hood, L (1970) Attachment of carbohydrate to the variable region of myeloma immunoglobulin light chains. Proc. Natl. Acad. Sci. U.S.A. 66: 975–982.
Staerz, UD and Bevan, MJ (1986) Hybrid hybridoma producing a bispecific monoclonal antibody that can focus effector T-cell activity. Proc. Natl. Acad. Sci. U.S.A. 83: 1453–1457.
Suresh, MR, Cuello, AC and Milstein, C (1986) Bispecific monoclonal antibodies from hybridomas. Methods Enzymol. 121: 210–228.
Wallick, SC, Kabat, EA and Morrison, SL (1988) Glycosylation of a monoclonal antibody against α (1–6) dextran increases its affinity for antigen. J. Exp. Med. 168: 1099–1109.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Tachibana, H., Akiyama, K., Shirahata, S. et al. Altered reactivity of immunoglobulin produced by human-human hybridoma cells transfected by pSV2-neo gene. Cytotechnology 6, 219–226 (1991). https://doi.org/10.1007/BF00624760
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00624760